IssuerAnnouncementDetailsV2Portlet
Actions
Dr. Soliman Abdel Kader Fakeeh Hospital Co. announces its Annual Financial results for the period ending on 2025-12-31
| Element List | Current Year | Previous Year | %Change | ||
|---|---|---|---|---|---|
| Sales/Revenue | 3,090.25 | 2,790.88 | 10.73 | ||
| Gross Profit (Loss) | 703.89 | 699.04 | 0.69 | ||
| Operational Profit (Loss) | 308 | 359.06 | -14.22 | ||
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 290.18 | 287.55 | 0.91 | ||
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 282.59 | 269.61 | 4.81 | ||
| Total Shareholders Equity (after Deducting Minority Equity) | 3,172.03 | 2,945.35 | 7.7 | ||
| Profit (Loss) per Share | 1.26 | 1.32 | |||
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year | Group revenue for the current year increased by 11% to SAR 3,091 million, compared with SAR 2,791 million in the previous year. This growth was primarily driven by an 8% increase in the number of patients served to 1.9 million, supported by continued demand across the Group’s network, particularly at its ramping-up hospitals in Riyadh and Madinah through the introduction and deepening of specialty services. Growth was also supported by the expansion in operational capacity at Group level, with operational beds increasing to 544 in 4Q25 from 457 in 4Q24, mainly driven by capacity additions at DSFH Riyadh and the phased opening of DSFH Madinah. Revenue growth further benefited from continued improvement in case mix toward higher-value, complex care. |
| The reason of the increase (decrease) in the net profit during the current year compared to the last year is | EBITDA for 2025 amounted to SAR 496 million, compared with SAR 522 million in the previous year. The year-on-year movement mainly reflects the ramp-up impact of DSFH Madinah, where front-loaded clinical capacity, operating readiness costs, and fixed overhead were carried ahead of full occupancy. Excluding DSFH Madinah’s impact, Group EBITDA would have increased to SAR 560 million compared with SAR 528 million in the previous year. Profit attributable to shareholders remained resilient at SAR 290 million in FY25, supported by growth in the Mature Business and uplift from DSFH Riyadh as it progressed further along its breakeven trajectory. Excluding DSFH Madinah's impact, attributable profits to shareholders would have increased by 14% year on year to SAR 332 million. This provides clear visibility on the underlying earnings strength of Fakeeh Care Group and the impact from facilities still in the early stages of ramp-up. |
| Statement of the type of external auditor's report | Unmodified opinion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | Not Applicable |
| Reclassification of Comparison Items | Certain comparative figures have been reclassified, wherever considered necessary, for the purpose of comparison and better presentation. |
| Additional Information | Not Applicable |
| Attached Documents |  |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 34.48
Net Change -0.24 (-0.69%)
Value Traded (Sar) 5,084,032.74
Volume Traded 149,137
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions